Imaging Quantification of Inflammation (IQI)
Running, not enrolling
Conditions studied: Uveitis
In brief
1\. Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change. Prospective use of changes in imaging quantification of inflammation (IQI) scores in determining treatment decisions both utilizing novel FA viewer software.
Key facts
- Study ID
- NCT04704609
- Run by
- The Cleveland Clinic
- People needed
- 50
- Starts
- 2019-09-22
- Expected to finish
- 2027-09-30
- Last updated by the study team
- 2026-03-04
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Any patient with a diagnosis of uveitis, who is deemed active or recently active (6 months) by a uveitis specialist
You may not qualify if…
- Poor view in fundus in both eyes which precludes image acquisition in those with posterior uveitis
- Those with posterior uveitis, any allergy to fluorescein
- Corneal opacities which prevent image acquisition
- Inability to sign consent
Where it is running
- Cleveland Clinic Foundation Cole Eye Institute — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.